Literature DB >> 29513031

Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial?

Anna M Kirby1.   

Abstract

The American Society of Radiation Oncology has recently updated its guidelines on the role of accelerated partial breast irradiation in the management of breast cancer. This commentary discusses the new recommendations and how we might advise patients in the light of existing data.

Entities:  

Mesh：

Year:  2018        PMID： 29513031      PMCID： PMC6190767          DOI： 10.1259/bjr.20170565

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  19 in total

1.  Radiotherapy for breast cancer, the TARGIT-A trial.

Authors:  Joanne S Haviland; Roger A'Hern; Soeren M Bentzen; Timothy Whelan; Judith M Bliss
Journal:  Lancet       Date:  2014-05-17       Impact factor: 79.321

2.  Radiotherapy for breast cancer, the TARGIT-A trial.

Authors:  Jack Cuzick
Journal:  Lancet       Date:  2014-05-17       Impact factor: 79.321

3.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).

Authors:  Csaba Polgár; Erik Van Limbergen; Richard Pötter; György Kovács; Alfredo Polo; Jaroslaw Lyczek; Guido Hildebrandt; Peter Niehoff; Jose Luis Guinot; Ferran Guedea; Bengt Johansson; Oliver J Ott; Tibor Major; Vratislav Strnad
Journal:  Radiother Oncol       Date:  2010-02-22       Impact factor: 6.280

4.  Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.

Authors:  Candace Correa; Eleanor E Harris; Maria Cristina Leonardi; Benjamin D Smith; Alphonse G Taghian; Alastair M Thompson; Julia White; Jay R Harris
Journal:  Pract Radiat Oncol       Date:  2016-09-17

5.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

Authors:  Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-15       Impact factor: 7.038

6.  Radiotherapy for breast cancer, the TARGIT-A trial.

Authors:  John Yarnold; Birgitte Vrou Offersen; Ivo Olivotto; Philip Poortmans; Rajiv Sarin
Journal:  Lancet       Date:  2014-05-17       Impact factor: 79.321

Review 7.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

8.  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Authors:  Charlotte E Coles; Clare L Griffin; Anna M Kirby; Jenny Titley; Rajiv K Agrawal; Abdulla Alhasso; Indrani S Bhattacharya; Adrian M Brunt; Laura Ciurlionis; Charlie Chan; Ellen M Donovan; Marie A Emson; Adrian N Harnett; Joanne S Haviland; Penelope Hopwood; Monica L Jefford; Ronald Kaggwa; Elinor J Sawyer; Isabel Syndikus; Yat M Tsang; Duncan A Wheatley; Maggie Wilcox; John R Yarnold; Judith M Bliss
Journal:  Lancet       Date:  2017-08-02       Impact factor: 79.321

9.  It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence.

Authors:  C C Kirwan; C E Coles; J Bliss
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-06-22       Impact factor: 4.126

10.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
View more
  5 in total

1.  Long-Term Results of Partial Breast Irradiation After Breast-Conserving Surgery for Early Stage Breast Cancer: A Prospective Phase II Trial in China.

Authors:  Yan Li; Lin Shui; Xiaodong Wang; Yu Sun; Renming Zhong; Pixian Shui; Nianyong Chen
Journal:  Front Oncol       Date:  2020-09-02       Impact factor: 6.244

Review 2.  The Role of Radiation Therapy in the Older Patient.

Authors:  Ammoren Dohm; Roberto Diaz; Ronica H Nanda
Journal:  Curr Oncol Rep       Date:  2021-01-02       Impact factor: 5.075

3.  Development and validation of a comprehensive patient-specific quality assurance program for a novel stereotactic radiation delivery system for breast lesions.

Authors:  Stewart J Becker; Ying Niu; Yildirim Mutaf; Shifeng Chen; Yannick Poirier; Elizabeth M Nichols; ByongYong Yi
Journal:  J Appl Clin Med Phys       Date:  2019-12       Impact factor: 2.102

4.  Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1.

Authors:  Jihye Choi; Yi Na Yoon; Nawon Kim; Chan Sub Park; Hyesil Seol; In-Chul Park; Hyun-Ah Kim; Woo Chul Noh; Jae-Sung Kim; Min-Ki Seong
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

5.  Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience.

Authors:  Hsin-Yi Yang; Chi-Wen Tu; Chien-Chin Chen; Cheng-Yen Lee; Yu-Chen Hsu
Journal:  Breast Cancer Res       Date:  2021-04-01       Impact factor: 6.466
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.